| Mcl-1 expression |  |  |  | |
---|---|---|---|---|---|
 | Weak | Strong | Total No. of patients (%) | Univariate analysis | Multivariate analysis |
<0.8 | ≥0.8 | ||||
No. of patients (%) | No. of patients (%) | P value* | P value* | ||
Number of patients | 15 (48.4) | 16 (51.6) | 31 (100) | – | – |
Age (years), mean ± SD | 57.3 ± 14.4 | 63.2 ± 11.8 | 60.4 ± 13.3 | 0.225 | 0.505 |
Sex | Â | Â | Â | Â | Â |
  Male | 7 (46.7) | 8 (50) | 15 (48.4) | 0.853 | 0.465 |
  Female | 8 (53.3) | 8 (50) | 16 (51.6) |  |  |
Symptom and signs | Â | Â | Â | Â | Â |
  Yes | 12 (80) | 11 (68.7) | 23 (74.2) | 0.474 |  |
  No | 3 (20) | 5 (31.3) | 8 (25.8) |  |  |
Tumor location | Â | Â | Â | Â | Â |
  Stomach | 5 (33.3) | 12 (75) | 17 (54.8) | 0.020 | 0.051 |
  Intestine | 10 (66.7) | 4 (25) | 14 (45.2) |  |  |
Tumor size (cm), mean ± SD | 8.0 ± 5.2 | 7.4 ± 4.5 | 7.7 ± 4.8 | 0.745 |  |
Mitosis (HPF), mean ± SD | 20.3 ± 22.9 | 16.1 ± 31.7 | 18.1 ± 27.4 | 0.672 |  |
Recurrence | Â | Â | Â | Â | Â |
  Yes | 5 (33.3) | 4 (25) | 9 (29) | 0.609 |  |
  No | 10 (66.7) | 12 (75) | 22 (71) |  |  |
Osteopontin expression** | Â | Â | Â | Â | Â |
  Strong | 5 (33.3) | 13 (81.3) | 18 (58.1) | 0.007 | 0.015 |
  Weak | 10 (66.7) | 3 (18.7) | 13 (41.9) |  |  |